A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults
Clinical trial NCT02390609 · COMPLETED
Trial details
- NCT number
- NCT02390609
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.